NO3063278T3 - - Google Patents

Info

Publication number
NO3063278T3
NO3063278T3 NO14858802A NO14858802A NO3063278T3 NO 3063278 T3 NO3063278 T3 NO 3063278T3 NO 14858802 A NO14858802 A NO 14858802A NO 14858802 A NO14858802 A NO 14858802A NO 3063278 T3 NO3063278 T3 NO 3063278T3
Authority
NO
Norway
Application number
NO14858802A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2013904242A external-priority patent/AU2013904242A0/en
Application filed filed Critical
Publication of NO3063278T3 publication Critical patent/NO3063278T3/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24111Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24111Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24111Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24151Methods of production or purification of viral material
    • C12N2710/24152Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO14858802A 2013-11-01 2014-11-03 NO3063278T3 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2013904242A AU2013904242A0 (en) 2013-11-01 Viral vector manufacture
AU2014900370A AU2014900370A0 (en) 2014-02-07 Orthopox vectors and propagation
PCT/AU2014/050330 WO2015061858A1 (en) 2013-11-01 2014-11-03 Viral vector manufacture

Publications (1)

Publication Number Publication Date
NO3063278T3 true NO3063278T3 (cg-RX-API-DMAC7.html) 2018-07-28

Family

ID=53003022

Family Applications (1)

Application Number Title Priority Date Filing Date
NO14858802A NO3063278T3 (cg-RX-API-DMAC7.html) 2013-11-01 2014-11-03

Country Status (24)

Country Link
US (2) US10544397B2 (cg-RX-API-DMAC7.html)
EP (2) EP3375882B1 (cg-RX-API-DMAC7.html)
JP (2) JP6682443B2 (cg-RX-API-DMAC7.html)
KR (1) KR102047030B1 (cg-RX-API-DMAC7.html)
CN (1) CN106255758B (cg-RX-API-DMAC7.html)
AU (1) AU2014344738B2 (cg-RX-API-DMAC7.html)
CA (1) CA2931518C (cg-RX-API-DMAC7.html)
CY (1) CY1121414T1 (cg-RX-API-DMAC7.html)
DK (2) DK3063278T3 (cg-RX-API-DMAC7.html)
ES (1) ES2670034T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20180789T1 (cg-RX-API-DMAC7.html)
HU (1) HUE037718T2 (cg-RX-API-DMAC7.html)
LT (1) LT3063278T (cg-RX-API-DMAC7.html)
NO (1) NO3063278T3 (cg-RX-API-DMAC7.html)
NZ (1) NZ720241A (cg-RX-API-DMAC7.html)
PL (1) PL3063278T3 (cg-RX-API-DMAC7.html)
PT (1) PT3063278T (cg-RX-API-DMAC7.html)
RS (1) RS57290B1 (cg-RX-API-DMAC7.html)
RU (1) RU2658487C2 (cg-RX-API-DMAC7.html)
SG (1) SG11201603919XA (cg-RX-API-DMAC7.html)
SI (1) SI3063278T1 (cg-RX-API-DMAC7.html)
SM (1) SMT201800267T1 (cg-RX-API-DMAC7.html)
TR (1) TR201807128T4 (cg-RX-API-DMAC7.html)
WO (1) WO2015061858A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2019001919A (es) * 2016-08-19 2019-09-04 Sementis Ltd Vacunas virales.
JP2018081568A (ja) * 2016-11-17 2018-05-24 グローリー株式会社 紙幣収納装置および紙幣処理機
CN119403822A (zh) * 2022-06-30 2025-02-07 巴法里安诺迪克有限公司 用于生产改良安卡拉痘苗病毒(mva)的哺乳动物细胞系
WO2024064608A2 (en) * 2022-09-20 2024-03-28 Intergalactic Therapeutics, Inc. Best1 vectors and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2604183B1 (fr) 1986-09-23 1988-12-30 Transgene Sa Sequence d'adn, vecteurs, virus recombinants et procede mettant en oeuvre des virus de la vaccine recombinants capables de se multiplier dans les cellules cho
DE69534289T2 (de) * 1994-04-29 2006-04-27 Baxter Healthcare S.A. Rekombinante Pockenviren mit fremden Polynukleotiden in wichtigen Regionen
ATE504653T1 (de) * 2002-08-07 2011-04-15 Bavarian Nordic As Vaccinia virus wirtspektrum gene zur erhöhung des titers von avipoxviren
FR2884255B1 (fr) * 2005-04-11 2010-11-05 Vivalis Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe
CN101541972A (zh) * 2006-08-04 2009-09-23 都柏林城市大学 生产重组生物产品的方法

Also Published As

Publication number Publication date
NZ720241A (en) 2019-10-25
SMT201800267T1 (it) 2018-07-17
AU2014344738A1 (en) 2016-06-09
CA2931518A1 (en) 2015-05-07
CY1121414T1 (el) 2020-05-29
EP3063278B1 (en) 2018-02-28
CN106255758A (zh) 2016-12-21
CA2931518C (en) 2021-03-09
HRP20180789T1 (hr) 2018-09-07
KR102047030B1 (ko) 2019-11-20
RU2016121425A (ru) 2017-12-04
EP3063278A1 (en) 2016-09-07
DK3375882T3 (da) 2019-12-16
RU2658487C2 (ru) 2018-06-21
HUE037718T2 (hu) 2018-09-28
WO2015061858A1 (en) 2015-05-07
PT3063278T (pt) 2018-05-25
SG11201603919XA (en) 2016-07-28
EP3375882A1 (en) 2018-09-19
RS57290B1 (sr) 2018-08-31
PL3063278T3 (pl) 2018-08-31
HK1223395A1 (en) 2017-07-28
DK3063278T3 (en) 2018-06-06
KR20160079868A (ko) 2016-07-06
JP2016534755A (ja) 2016-11-10
EP3063278A4 (en) 2017-04-12
US20200190482A1 (en) 2020-06-18
SI3063278T1 (sl) 2019-04-30
ES2670034T3 (es) 2018-05-29
JP2020039340A (ja) 2020-03-19
AU2014344738B2 (en) 2019-03-21
CN106255758B (zh) 2020-06-23
EP3375882B1 (en) 2019-10-16
TR201807128T4 (tr) 2018-06-21
JP6682443B2 (ja) 2020-04-15
US10544397B2 (en) 2020-01-28
LT3063278T (lt) 2018-07-10
US20170029784A1 (en) 2017-02-02

Similar Documents

Publication Publication Date Title
AP2016009275A0 (cg-RX-API-DMAC7.html)
BR112015007533A2 (cg-RX-API-DMAC7.html)
BR102016010778A2 (cg-RX-API-DMAC7.html)
BR112014017733A2 (cg-RX-API-DMAC7.html)
BR112014018502A2 (cg-RX-API-DMAC7.html)
BR112014017739A2 (cg-RX-API-DMAC7.html)
BR112014019326A2 (cg-RX-API-DMAC7.html)
BR112014018480A2 (cg-RX-API-DMAC7.html)
BR112014018516A2 (cg-RX-API-DMAC7.html)
BR112014020341A2 (cg-RX-API-DMAC7.html)
BR112014017855A2 (cg-RX-API-DMAC7.html)
BR112014017765A2 (cg-RX-API-DMAC7.html)
BR112014017669A2 (cg-RX-API-DMAC7.html)
BR112014021878A2 (cg-RX-API-DMAC7.html)
BR112014018468A2 (cg-RX-API-DMAC7.html)
BR112014017901A2 (cg-RX-API-DMAC7.html)
BR112014019204A2 (cg-RX-API-DMAC7.html)
BR112014018207A2 (cg-RX-API-DMAC7.html)
BR112014017722A2 (cg-RX-API-DMAC7.html)
BR112014017653A2 (cg-RX-API-DMAC7.html)
BR112014018578A2 (cg-RX-API-DMAC7.html)
BR112014018483A2 (cg-RX-API-DMAC7.html)
BR112014017794A2 (cg-RX-API-DMAC7.html)
BR112014017601A2 (cg-RX-API-DMAC7.html)
BR112015015312A2 (cg-RX-API-DMAC7.html)